Emerging studies suggest Retatru tide , a dual stimulator targeting both GLP-1 and GIP , may offer a significant advancement for obesity management . Early clinical trials have shown considerable losses in visceral fat , conceivably exceeding existing obesity therapies . Nevertheless , further study is required to completely assess its sustained… Read More